Schmitz, R. S., van den Belt-Dusebout, A. W., Clements, K., Ren, Y., Cresta, C., Timbres, J., … Schmidt, M. K. (2022). Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients. In CANCER RESEARCH (Vol. 82).

Schmitz, Renee S., Alexandra W. van den Belt-Dusebout, Karen Clements, Yi Ren, Chiara Cresta, Jasmine Timbres, Yat-Hee Liu, et al. “Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients.” In CANCER RESEARCH, Vol. 82, 2022.

Schmitz RS, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, et al. Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients. In: CANCER RESEARCH. 2022.

Schmitz, Renee S., et al. “Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients.” CANCER RESEARCH, vol. 82, no. 12, 2022.

Schmitz RS, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, Liu Y-H, Byng D, Lynch T, Menegaz B, Collyar D, Hyslop T, Schaapveld M, Sawyer E, Hwang SE, Thompson A, Ryser MD, Wesseling J, Lips EH, Schmidt MK. Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients. CANCER RESEARCH. 2022.